Prestige Consumer Healthcare In
PBH
Jodie situation report
Prestige Consumer Healthcare In's move is being confirmed by its market group.
PBH accounts for 12.7% of the group's measured movement across 7.1 effective names. raw member direction is mixed; 0 of 11 SPY-adjusted paths align to the mixed. Capital-flow agreement is 28%, so confirmation is not yet clean. No verified headline preceded the measured group move.
Is this move genuinely shared?
ATRC, MRK, PFE moved materially before PBH. PBH crossed its material path threshold at 11:20 ET, 50 minutes after the first measured mover. RPRX, BMY, JNJ followed.
- Revenue increased 6.5% versus the comparable filing period.
- Operating margin fell 9.0 percentage points.
6 of 11 members in Biopharmaceuticals and Care are active. 0 of 2 disclosed connections are confirming.
- At least 8 of 11 durable members become active together.
- Capital-flow agreement rises above 55%.
- A filing-linked outsider such as INVA begins moving with the group.
Invalidation: The live read weakens if participation falls to 3 of 11 members or fewer.
Who this business touches
The relationships behind PBH
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
WMT20.0% of PBHcustomerMay 14, 2026 ▾
“During 2026, Walmart and Amazon, which accounted for approximately 20% and 15%, respectively, of our gross revenues, were our only customers that accounted for more than 10% of our gross revenues.”
AMZN15.0% of PBHcustomerMay 14, 2026 ▾
“During 2026, Walmart and Amazon, which accounted for approximately 20% and 15%, respectively, of our gross revenues, were our only customers that accounted for more than 10% of our gross revenues.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 7 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
PBH is currently a Leader in the organic co-movement group Biopharmaceuticals and Care. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 2 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.